Abstract
Differences in cardiovascular disease outcomes between men and women have long been recognized and attributed, in part, to gender and sex steroids. Gender dimorphisms also exist with respect to the roles of progenitor and stem cells in post-ischemic myocardial and endothelial repair and regeneration. Understanding how these cells are influenced by donor gender and the recipient hormonal milieu may enable researchers to further account for the gender-related disparities in clinical outcomes as well as utilize the beneficial effects of these hormones to optimize transplanted cell function and survival. This review discusses (1) the cardiovascular effects of sex steroids (specifically estradiol and testosterone); (2) the therapeutic potentials of endothelial progenitor cells, mesenchymal stem cells, and embryonic stem cells; and (3) the direct effect of sex steroids on these cell types.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 103-113 |
| Number of pages | 11 |
| Journal | Journal of Cardiovascular Translational Research |
| Volume | 3 |
| Issue number | 2 |
| DOIs | |
| State | Published - Apr 2010 |
| Externally published | Yes |
Keywords
- Cardiovascular disease
- Gender differences
- Progenitor cells
- Sex steroids
- Stem cell therapy
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Genetics(clinical)
- Genetics
- Molecular Medicine
- Pharmaceutical Science